HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra Mendoza Selected Research

Sandra Mendoza Research Topics

Disease

2Major Depressive Disorder (Major Depressive Disorders)
08/2010 - 02/2010
1COVID-19
01/2022
1Lung Neoplasms (Lung Cancer)
04/2018
1Neoplasms (Cancer)
04/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2018
1Carcinogenesis
06/2015
1Callosities
06/2015
1Adenocarcinoma
06/2015
1Hyponatremia
01/2013
1Hypersensitivity (Allergy)
01/2013
1Melanoma (Melanoma, Malignant)
01/2013
1Neutropenia
01/2013
1Thrombocytopenia (Thrombopenia)
01/2013
1Renal Insufficiency (Renal Failure)
01/2013
1Familial Dysautonomia (Riley Day Syndrome)
11/2011

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
04/2018 - 11/2011
2Biomarkers (Surrogate Marker)IBA
04/2018 - 01/2018
2EnzymesIBA
06/2015 - 02/2010
1Thyroid Nuclear Factor 1IBA
04/2018
1GlucuronidaseIBA
06/2015
11,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
06/2015
1Anticarcinogenic AgentsIBA
06/2015
1Dimenhydrinate (DMH)FDA LinkGeneric
06/2015
1CateninsIBA
06/2015
1130-nm albumin-bound paclitaxelIBA
01/2013
1Albumin-Bound PaclitaxelFDA Link
01/2013
1Temozolomide (Temodar)FDA LinkGeneric
01/2013
1CreatinineIBA
01/2013
1Dacarbazine (DIC)FDA LinkGeneric
01/2013
1oblimersen (G3139)IBA
01/2013
1Antisense OligonucleotidesIBA
01/2013
1Messenger RNA (mRNA)IBA
11/2011
1Phosphotransferases (Kinase)IBA
11/2011
1KinetinIBA
11/2011
1Biological ProductsIBA
08/2010
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
02/2010
1CytokinesIBA
02/2010

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2022 - 01/2013